Korean Pharma, Biotech Firms Post Strong Q1 Sales While Profitability Diverges

Samsung BiologicsKorean Pharma, Biotech Firms Post Strong Q1 Sales While Profitability Diverges - thelec.net

Charles RiverNeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo Finance

Insilico MedicineInSilico Ribo Oligonucleotide Alliance Tests AI Drug Discovery Model - simplywall.st

BioWorldWHO declares Ebola outbreak a public health emergency of international concern

Eli LillyPharma Earnings Season 2026: Amphastar Flat, Eli Lilly Surges in Q1 - News and Statistics - IndexBox

Insilico MedicineInsilico Medicine Showcases AI-Driven Inhaled Therapy for Pulmonary Fibrosis at ATS Summit - TipRanks

Samsung BiologicsCDMOs turn to pharma facility acquisitions amid manufacturing realignment: GlobalData - megaproject.com

Thermo FisherIs It Time To Reconsider Thermo Fisher Scientific (TMO) After Its Recent Share Price Slide? - simplywall.st

AmgenAmgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWS

IlluminaIllumina Inc stock (US4523271090): gene sequencing player in focus after latest earnings and divesti - AD HOC NEWS

Merck & Co.Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWS

Charles RiverCharles River Labs stock (US14149Y1082): 4.45% slide puts support zone back in focus - AD HOC NEWS